Literature DB >> 8367445

Mutations of von Willebrand factor gene in families with von Willebrand disease in the Aland Islands.

Z P Zhang1, M Blombäck, D Nyman, M Anvret.   

Abstract

Patients with von Willebrand disease in four families in the Aland Islands, including the original family that was described in 1926 by the Finnish physician von Willebrand, were screened for mutations in the Swedish "hot-spot" regions (exons 18, 28, 32, 43, and 45) of the von Willebrand factor gene. One cytosine deletion in exon 18 was detected in each of these families. Linkage analysis and genealogical studies suggest that the deletion present in these four families probably has an origin in common with the mutations in the Swedish patients. Apart from the deletion in exon 18, two close transitions (G-->A at S1263 and C-->T at P1266) in exon 28 on the same chromosome were identified in one individual who married into the original family and in his two children. The transitions could be due to a recombination between the von Willebrand factor gene and its pseudogene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8367445      PMCID: PMC47262          DOI: 10.1073/pnas.90.17.7937

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  v. Willebrand's disease in Sweden; its pathogenesis and treatment.

Authors:  I M NILSSON; M BLOMBACK; B BLOMBACK
Journal:  Acta Med Scand       Date:  1959-06-30

2.  A single cytosine deletion in exon 18 of the von Willebrand factor gene is the most common mutation in Swedish vWD type III patients.

Authors:  Z P Zhang; G Falk; M Blombäck; N Egberg; M Anvret
Journal:  Hum Mol Genet       Date:  1992-12       Impact factor: 6.150

3.  On laboratory problems in diagnosing mild von Willebrand's disease.

Authors:  M Blombäck; P Eneroth; O Andersson; M Anvret
Journal:  Am J Hematol       Date:  1992-06       Impact factor: 10.047

4.  Influence of age, sex and blood groups on 15 blood coagulation laboratory variables in a reference material composed of 80 blood donors.

Authors:  T B Wahlberg; G F Savidge; M Blombäck; B Wiechel
Journal:  Vox Sang       Date:  1980-12       Impact factor: 2.144

5.  Structure of the gene for human von Willebrand factor.

Authors:  D J Mancuso; E A Tuley; L A Westfield; N K Worrall; B B Shelton-Inloes; J M Sorace; Y G Alevy; J E Sadler
Journal:  J Biol Chem       Date:  1989-11-25       Impact factor: 5.157

6.  Inherited defective platelet aggregation with arachidonate as the main expression of a defective metabolism of arachidonic acid.

Authors:  D Nyman; A W Eriksson; W Lehmann; M Blombäck
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

7.  Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.

Authors:  M Anvret; M Blombäck; M Lindstedt; E Söderlind; M Tapper-Persson; A C Thelander
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

8.  Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction.

Authors:  D J Mancuso; E A Tuley; L A Westfield; T L Lester-Mancuso; M M Le Beau; J M Sorace; J E Sadler
Journal:  Biochemistry       Date:  1991-01-08       Impact factor: 3.162

9.  Dinucleotide repeat polymorphism in the promoter region of the human von Willebrand factor gene (vWF gene).

Authors:  Z P Zhang; L P Deng; M Blombäck; M Anvret
Journal:  Hum Mol Genet       Date:  1992-12       Impact factor: 6.150

10.  Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.

Authors:  Z P Zhang; M Lindstedt; G Falk; M Blombäck; N Egberg; M Anvret
Journal:  Am J Hum Genet       Date:  1992-10       Impact factor: 11.025

View more
  6 in total

1.  A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.

Authors:  W Deng; Y Wang; S A Druzak; J F Healey; A K Syed; P Lollar; R Li
Journal:  J Thromb Haemost       Date:  2017-08-09       Impact factor: 5.824

2.  Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence.

Authors:  J C Eikenboom; T Vink; E Briët; J J Sixma; P H Reitsma
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

3.  Effects of the mutant von Willebrand factor gene in von Willebrand disease.

Authors:  Z Zhang; M Lindstedt; M Blombäck; M Anvret
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

4.  The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.

Authors:  M Bowman; A Tuttle; C Notley; C Brown; S Tinlin; M Deforest; J Leggo; V S Blanchette; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2013-03       Impact factor: 5.824

Review 5.  The molecular characterization of von Willebrand disease: good in parts.

Authors:  P D James; D Lillicrap
Journal:  Br J Haematol       Date:  2013-02-14       Impact factor: 6.998

6.  Association between Genetic Polymorphism and Risk of von Willebrand Disease in Pakistan.

Authors:  Najma Arshad; Syed Kashif Nawaz; Riffat Iqbal; Muhammad Arshad; Farhana Musheer; Amber Naz; Iqra Mushtaq; Sara Jaleel
Journal:  Biomed Res Int       Date:  2017-12-20       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.